// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Based on GDP per capita, Armenia ranks the 40th among developed countries, again outperformed by Turkey, Azerbaijan, Iran and Georgia.
With 119 countries reported, Armenia has a rating of 33.87 and is placed 19th among the least expensive countries.
The Armenian Government is set to approve a presidential decree on establishing a Consulate General in Dubai, UAE.
The situation along the border with Azerbaijan was relatively calm, no shots were fired overnight on December 29-30, Artsrun Hovhannisyan said.
Partner news